Shopping Cart
Remove All
Your shopping cart is currently empty
PKN3-IN-1 (compound 16) inhibits PKN3 (serine/threonine-protein kinase N3) and GAK (cyclin G-associated kinase) with an IC50 of 0.014 μM and a Ki of 0.0044 μM. PKN3-IN-1 is a potential tool compound for investigating the cell biology of PKN3 and its role in pancreatic and prostate cancers, as well as T-cell acute lymphoblastic leukemia.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | 10-14 weeks | 10-14 weeks | |
| 50 mg | Inquiry | 10-14 weeks | 10-14 weeks |
| Description | PKN3-IN-1 (compound 16) inhibits PKN3 (serine/threonine-protein kinase N3) and GAK (cyclin G-associated kinase) with an IC50 of 0.014 μM and a Ki of 0.0044 μM. PKN3-IN-1 is a potential tool compound for investigating the cell biology of PKN3 and its role in pancreatic and prostate cancers, as well as T-cell acute lymphoblastic leukemia. |
| In vitro | PKN3-IN-1, at a concentration of 1 μM over 48 hours, inhibits PKN3 in HEK 293 cells with an IC50 of 0.014 μM [1]. Additionally, PKN3-IN-1, at 1 μM over 24 hours, inhibits GAK with a Ki of 0.0044 μM in the same cell line [2]. At 1.3 μM, PKN3-IN-1 demonstrates intracellular target-binding capability below 5 μM [1]. |
| Molecular Weight | 436.244 |
| Formula | C18H17IN2O3 |
| Cas No. | 2361545-75-5 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.